Table of Contents:

1 Executive Summary
2 Market Introduction
2.1 Introduction
2.2 Assumptions & Limitations
2.2.1 Assumptions
2.2.2 Limitations
2.3 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Data Mining
3.3 Secondary Research
3.4 Primary Research
3.5 Forecasting Techniques
3.6 Research Methodology for Market Size Estimation
3.6.1 Bottom-Up Approach
3.6.2 Top-Down Approach
3.6.3 Data Triangulation
3.6.4 Validation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising Cases of Gastrointestinal Disorders
4.2.2 Increasing Awareness About Lactose Intolerance and Related Complications
4.2.3 Increased Prevalence of Lactose Intolerance
4.3 Restraints
4.3.1 Side-Effects Associated with Supplements
4.4 Opportunities
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Monitoring
5.2 Porter's Five Forces Model
5.2.1 Threat of New Entrants
5.2.2 Bargaining Power of Suppliers
5.2.3 Threat of Substitutes
5.2.4 Bargaining Power of Buyers
5.2.5 Intense Rivalry
5.3 Investment Opportunities
6 Global Lactose Intolerance Treatment Market, by Type
6.1 Introduction
6.2 Primary Lactose Intolerance
6.3 Secondary Lactose Intolerance
6.4 Congenital/Developmental Lactose Intolerance
7 Global Lactose Intolerance Treatment Market, by Treatment
7.1 Introduction
7.2 Food Supplements
7.3 Enzyme Lactase Supplements
7.4 Probiotics
8 Global Lactose Intolerance Treatment Market, by Form
8.1 Introduction
8.2 Powder
8.3 Liquid
8.4 Tablets & Capsules
9 Global Lactose Intolerance Treatment Market by, End User
9.1 Introduction
9.2 Homecare
9.3 Hospitals & Clinics
10 Global Lactose Intolerance Treatment Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 UK
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Australia
10.4.3 Japan
10.4.4 India
10.4.5 South Korea
10.4.6 Rest of the Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1 Introduction
11.2 Company Share Analysis
12 Company Profiles
12.1 Johnson & Johnson Services, Inc.
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products/Services Offered
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategies
12.2 Nestle
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products/Services Offered
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategies
12.3 Abbott
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products/Services Offered
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategies
12.4 Deerland Enzymes, Inc.
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products/Services Offered
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategies
12.5 Ritter Pharmaceuticals
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products/Services Offered
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategies
12.6 Guardian Drug Company
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products/Services Offered
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategies
12.7 Novozymes
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products/Services Offered
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategies
12.8 Cargill, Incorporated
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products/Services Offered
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategies
12.9 Arla Foods
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products/Services Offered
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategies
12.1 Dean Foods
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products/Services Offered
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategies
13 Appendix
13.1 References
13.2 Related Reports